Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlorhexidine vs Potassium Permanganate for Prevention of Nosocomial Pneumonia in ICU
NCT00610324Phase 4Completed
- Sponsor
- King Edward Memorial Hospital
- Start
- May 2004
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chlorhexidine in hospital-acquired pneumonia (HAP) (2 arms), sponsored by King Edward Memorial Hospital. Primary endpoint: Development of nosocomial pneumonia. Started May 2004; status: completed.
02
Drugs
chlorhexidine
03
Conditions
hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on NCT00610324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610324.